[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Immuneering Immuneering Corp
Immuneering Corp posts on X about $imrx, live from, promising, vienna the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXX +1,728%
- X Month XXXXX +10%
- X Months XXXXX +314%
- X Year XXXXX +1,299%
Mentions: X #
- X Week X +400%
- X Month X +167%
- X Months XX +100%
- X Year XX +500%
Followers: XXX #
- X Month XXX +19%
- X Months XXX +39%
- X Year XXX +48%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence exchanges travel destinations stocks
Social topic influence $imrx #1, live from, promising, vienna, momentum, $200m, $25m, sanofi
Top assets mentioned Sanofi (SNY)
Top Social Posts #
Top posts by engagements in the last XX hours
"Were proud to be a 2025 #ScripAwards finalist as Best Oncology R&D Advance for our Phase 2a trial of atebimetinib in pancreatic cancer This honor reflects our commitment to advancing new treatments that aim to help patients live longer & feel better. #Oncology #CancerResearch"
X Link @Immuneering 2025-10-07T16:00Z XXX followers, XXX engagements
"$IMRX and @BenZeskind were honored to join @bradloncar and @BiotechTV live from the NYSE to discuss our latest progress in oncology including promising pancreatic cancer data and our deep cyclic inhibitors. Watch the full video here:"
X Link @Immuneering 2025-10-10T15:34Z XXX followers, XXX engagements
"Meet us in Vienna during #BIOEurope taking place Nov 3-5 Our CBO E.B. Brakewood will be onsite to meet with global business leaders and industry experts in the biotech & pharma fields. Learn more about $IMRX and our pipeline:"
X Link @Immuneering 2025-10-13T16:00Z XXX followers, XXX engagements
"Our clinical data featured in @TargetedOnc highlight the potential of our investigational therapy atebimetinib in combination with chemotherapy to help address pancreatic cancer an area of urgent unmet need"
X Link @Immuneering 2025-10-09T16:00Z XXX followers, XXX engagements
"ICYMI: $IMRX ended Sept. with strong momentum: XX% 9-month survival in 1L pancreatic cancer (atebimetinib + mGnP) and a $200M financing including $25M from Sanofi. Webcast replay:"
X Link @Immuneering 2025-10-15T15:20Z XXX followers, XXX engagements